| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.051 | 0.4 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |